Data from multiple sources - Curated by Toby Galbraith - Last updated 04 January 2017
Latest news articles
Added 8 days ago Drug news
Phase III EPOCH study evaluating MK 8931 (verubecestat) in people with mild-to-moderate Alzheimer’s disease halted- Merck Inc
Merck Inc announced that it will be stopping protocol 017, also known as the EPOCH study, a Phase II/III study...
Added 14 days ago Drug news
Phase III clinical data of CVT 301 (inhaled levodopa) shows improvement in Parkinsons disease patients- Acorda Therapeutics
Acorda Therapeutics announced Phase III clinical data of CVT 301 (inhaled levodopa), showing a statistically significant improvement in motor function...
Added 15 days ago Drug news
Idalopirdine fails further trials (STARBEAM and STARBRIGHT) as a treatment for Alzheimers disease -Lundbeck + Otuska
Idalopirdine (LuAE 58054),a 5HT6 antagonist being developed by Lundbeck and Otsuka for the symptomatic treatment of patients with mild to...
An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.
American Association Of Clinical Endocrinologists And American College Of Endocrinology Comprehensive Clinical Practice Guidelines For Medical Care Of Patients With Obesity
Development of these guidelines is mandated by the American Association of Clinical Endocrinologists (AACE) Board of Directors and the American College of Endocrinology...
Added 2 months ago
The ESMO Clinical Practice Guideline in multiple myeloma, which accounts for approximately 10% of all haematological malignancies, covers recommendations for diagnosis; staging and risk assessment...
Added 4 months ago
This guideline covers the clinical care of adults (18 years and over) who are dying during the last 2 to...
Added 1 year ago
Advanced heart failure is a malignant disease characterized by a debilitating late course, with increasingly frequent hospitalisations and high rate of mortality.
Added 4 hours ago
The effects of levosimendan and OR-1896 on isolated hearts, myocyte-sized preparations and phosphodiesterase enzymes of the guinea pig
The concentration dependences of the Ca2+-sensitizing and the phosphodiesterase-inhibitory effects of levosimendan...
Added 5 hours ago
Levosimendan, a novel Ca2+ sensitizer, activates the glibenclamide-sensitive K+ channel in rat arterial myocytes
The electrophysiological effect of levosimendan, a novel Ca(2+)-sensitizing positive inotropic agent and vasodilator, was examined on rat mesenteric arterial myocytes using the patch clamp technique.
Added 9 hours ago
Posted 2 years ago
Would you trust a doctor to decide if you are an appropriate subject for assisted dying? I wouldn't, neither should you, and my colleagues who are not fortunate enough to be retired will be crazy if they allow themselves to be dragged into the process. Proponents of legislative change should man up and face the implications of their proposals, without hiding behind the medical profession.
Posted 1 year ago
I presented this talk, "The End of Sight at the End of Life," on 4/4/2013 at a Harvard University "Think Tank" on Health and Aging. The two-day conference, held at the Charles Hotel in Cambridge, Massachusetts, brought together prominent scholars from the Harvard School of Public Health as well as global experts in economics, health care policy and longevity, for a fascinating and thought-provoking colloquium on the demographics and consequences of aging in all societies.
- Accrediting body
- Union of European Medical Specialists (via European Accreditation Council for CME)
- Credits available
- Registration required
- Subscription fee